← Back to Search

Yoga Program for Survivorship

N/A

Waitlist Available

Led By Jenson Price, PhD c

Research Sponsored by University of Ottawa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of study (12 months)

Awards & highlights

Study Summary

This trial aims to create a yoga program for adults with gynecologic cancer to address their body image, sexual functioning and emotional wellbeing. Stakeholders from academia, healthcare, and ORCF will partner to evaluate the program's feasibility and acceptability.

Eligible Conditions

Survivorship
Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of study (12 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of study (12 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of study (12 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of trial and program - Instructor

Acceptability of trial and program - Participants

Instructor fidelity to the program

+6 more

Secondary outcome measures

Body image

Cognitive functioning

Embodiment

+5 more

Other outcome measures

Sociodemographic and medical characteristics

Trial Design

1Treatment groups

Experimental Treatment

Group I: Yoga ProgramExperimental Treatment1 Intervention

Participants will receive a yoga program program in-person or via real-time videoconferencing (if they choose).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Yoga Program

2022

N/A

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OttawaLead Sponsor

207 Previous Clinical Trials

267,121 Total Patients Enrolled

The Ottawa HospitalOTHER

93 Previous Clinical Trials

62,898 Total Patients Enrolled

Jenson Price, PhD cPrincipal InvestigatorUniversity of Ottawa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies to participate in this research endeavor?

"The clinical trial, as listed on its registrative page hosted by clinicaltrials.gov, is not currently enlisting patients. The study was first advertised on the 1st of November 2022 and underwent a final update three days later; however, there are 517 other studies that are actively recruiting individuals at this moment in time."

Answered by AI

What results are researchers hoping to gain from this medical experiment?

"This clinical trial seeks to evaluate the program adherence of patients over a period of 12 months. Secondary metrics for assessment include perceived stress (Perceived Stress Scale), sexual distress (Female Sexual Distress Scale-Revised), and cognitive functioning (Functional Assessment of Cancer Therapy - Cognitive Function). All assessments use a scale range from 0 to 4, where higher scores indicate greater levels of distress or perceived abilities."

Answered by AI

Recent research and studies

Journal of Clinical OncologyJournal

The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure.

Cella, D F, D S Tulsky, G Gray, B Sarafian, E Linn, A Bonomi, M Silberman, S B Yellen, P Winicour, and J Brannon. 1993. “The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure.”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.1993.11.3.570.

Behavior TherapyJournal

Preliminary Psychometric Properties of the Acceptance and Action Questionnaire–ii: A Revised Measure of Psychological Inflexibility and Experiential Avoidance

Bond, Frank W., Steven C. Hayes, Ruth A. Baer, Kenneth M. Carpenter, Nigel Guenole, Holly K. Orcutt, Tom Waltz, and Robert D. Zettle. 2011. “Preliminary Psychometric Properties of the Acceptance and Action Questionnaire–ii: A Revised Measure of Psychological Inflexibility and Experiential Avoidance”. Behavior Therapy. Elsevier BV. doi:10.1016/j.beth.2011.03.007.

Journal of Pain and Symptom ManagementJournal

Measuring Fatigue and Other Anemia-related Symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System

Yellen, Suzanne B., David F. Cella, Kimberly Webster, Carol Blendowski, and Edward Kaplan. 1997. “Measuring Fatigue and Other Anemia-related Symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System”. Journal of Pain and Symptom Management. Elsevier BV. doi:10.1016/s0885-3924(96)00274-6.

Journal of Behavioral MedicineJournal